Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2009 3
2010 6
2011 6
2012 4
2013 6
2014 5
2015 5
2016 5
2017 4
2018 4
2019 4
2020 5
2021 8
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium.
Diefenbach MA, Marziliano A, Tagai EK, Pfister H, Lapitan E, Hall SJ, Vira M, Ibrahim S, Aibel K, Kutikov A, Horwitz EM, Miyamoto C, Reese AC, Miller SM. Diefenbach MA, et al. Among authors: reese ac. J Med Internet Res. 2023 Oct 20;25:e46552. doi: 10.2196/46552. J Med Internet Res. 2023. PMID: 37862103 Free PMC article. Clinical Trial.
Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men.
Epstein M, Syed K, Danella J, Ginzburg S, Belkoff L, Tomaszewski J, Trabulsi E, Singer EA, Jacobs BL, Raman JD, Guzzo TJ, Uzzo R, Reese AC. Epstein M, et al. Among authors: reese ac. Prostate Cancer Prostatic Dis. 2023 Oct 11. doi: 10.1038/s41391-023-00727-6. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37821578
Defining aggressive prostate cancer: a geospatial perspective.
Wiese D, DuBois TD, Sorice KA, Fang CY, Ragin C, Daly MB, Reese AC, Henry KA, Lynch SM. Wiese D, et al. Among authors: reese ac. BMC Cancer. 2023 Aug 14;23(1):754. doi: 10.1186/s12885-023-11281-8. BMC Cancer. 2023. PMID: 37580675 Free PMC article.
Longitudinal Changes in the Operative Experience for Junior Urology Residents.
Margolin EJ, Schoenfeld D, Miles CH, Merrill SB, Raman JD, Thompson RH, Reese AC, Parekh DJ, Brown ET, Klausner A, Williams DH, Lee RK, Zaslau S, Guzzo TJ, Shenot PJ, Anderson CB, Badalato GM. Margolin EJ, et al. Among authors: reese ac. Urology. 2023 Sep;179:32-38. doi: 10.1016/j.urology.2023.03.064. Epub 2023 Jul 1. Urology. 2023. PMID: 37400019
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group.
Douglawi A, Ghoreifi A, Carbonara U, Yip W, Uzzo RG, Margulis V, Ferro M, Cobelli O, Wu Z, Simone G, Mastroianni R, Rha KH, Eun DD, Reese AC, Porter JR, Derweesh I, Mehrazin R, Rosiello G, Tellini R, Jamil M, Kenigsberg A, Farrow JM, Schrock WP, Cacciamani G, Srivastava A, Bhattu AS, Mottrie A, Gonzalgo ML, Sundaram CP, Abdollah F, Minervini A, Autorino R, Djaladat H. Douglawi A, et al. Among authors: reese ac. Clin Genitourin Cancer. 2023 Oct;21(5):563-568. doi: 10.1016/j.clgc.2023.05.011. Epub 2023 May 24. Clin Genitourin Cancer. 2023. PMID: 37301663
Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy.
Kenigsberg AP, Carpinito G, Gold SA, Meng X, Ghoreifi A, Djaladat H, Minervini A, Jamil M, Abdollah F, Farrow JM, Sundaram C, Uzzo R, Ferro M, Meagher M, Derweesh I, Wu Z, Porter J, Katims A, Mehrazin R, Mottrie A, Simone G, Reese AC, Eun DD, Bhattu AS, Gonzalgo ML, Carbonara U, Autorino R, Margulis V. Kenigsberg AP, et al. Among authors: reese ac. Urol Oncol. 2022 Oct;40(10):452.e17-452.e23. doi: 10.1016/j.urolonc.2022.06.006. Epub 2022 Aug 4. Urol Oncol. 2022. PMID: 35934609
Robotic vs Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group).
Veccia A, Carbonara U, Djaladat H, Mehazin R, Eun DD, Reese AC, Meng X, Uzzo R, Srivastava A, Porter J, Farrow JM, Jamil ML, Rosiello G, Tellini R, Mari A, Al-Qathani A, Rha KH, Wang L, Mastroianni R, Ferro M, De Cobelli O, Hakimi K, Crocerossa F, Ghoreifi A, Cacciamani G, Bhattu AS, Mottrie A, Abdollah F, Minervini A, Wu Z, Simone G, Derweesh I, Gonzalgo ML, Margulis V, Sundaram CP, Autorino R. Veccia A, et al. Among authors: reese ac. J Endourol. 2022 Jun;36(6):752-759. doi: 10.1089/end.2021.0587. Epub 2022 Feb 25. J Endourol. 2022. PMID: 35019760
Reply by Authors.
Bernstein AN, Talwar R, Handorf E, Syed K, Danella J, Ginzburg S, Belkoff L, Reese AC, Tomaszewski J, Trabulsi E, Jacobs B, Singer EA, Raman J, Smaldone M, Uzzo R, Guzzo T, Correa A. Bernstein AN, et al. Among authors: reese ac. Urol Pract. 2021 Nov;8(6):675. doi: 10.1097/UPJ.0000000000000261.02. Epub 2021 Aug 23. Urol Pract. 2021. PMID: 37145535 No abstract available.
Impact of COVID-19 on Initial Management and Evaluation of Prostate Cancer.
Bernstein AN, Talwar R, Handorf E, Syed K, Danella J, Ginzburg S, Belkoff L, Reese AC, Tomaszewski J, Trabulsi E, Jacobs B, Singer EA, Raman J, Smaldone M, Uzzo R, Guzzo T, Correa A. Bernstein AN, et al. Among authors: reese ac. Urol Pract. 2021 Nov;8(6):668-675. doi: 10.1097/UPJ.0000000000000261. Epub 2021 Aug 23. Urol Pract. 2021. PMID: 37145514
59 results